Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDQuest Diagnostics Incorporated Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 10 | $2.10 | $2.20 | $2.15 |
| Q2 2025 | 14 | $2.54 | $2.68 | $2.57 |
| Q3 2025 | 7 | $2.51 | $2.51 | $2.51 |
| Q4 2025 | 7 | $2.41 | $2.41 | $2.41 |
| Q1 2026 | 6 | $2.40 | $2.40 | $2.40 |
| Q2 2026 | 11 | $2.80 | $2.80 | $2.80 |
| Q3 2026 | 6 | $2.70 | $2.70 | $2.70 |
| Q4 2026 | 10 | $2.60 | $2.60 | $2.60 |
| Q1 2027 | 10 | $2.52 | $2.52 | $2.52 |
| Q2 2027 | 6 | $3.02 | $3.02 | $3.02 |
| Q3 2027 | 7 | $2.90 | $2.90 | $2.90 |
| Q4 2027 | 6 | $2.76 | $2.76 | $2.76 |
Quest Diagnostics Incorporated Earnings Date And Information
Quest Diagnostics Incorporated last posted its earnings results on Tuesday, April 22nd, 2025. The company reported $2.21 earnings per share for the quarter, topping analysts' consensus estimates of $2.15 by $0.06. The company had revenue of 2.65 B for the quarter and had revenue of 9.87 B for the year. Quest Diagnostics Incorporated has generated $8 earnings per share over the last year ($7.69 diluted earnings per share) and currently has a price-to-earnings ratio of 20.81. Quest Diagnostics Incorporated has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, July 22nd, 2025 based on prior year's report dates.
Quest Diagnostics Incorporated Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 04/23/2025 | Q1 2025 | N/A | $1.97 | N/A | $2.63 B | $2.65 B |
| 02/20/2025 | Q4 2024 | N/A | $1.98 | N/A | $2.58 B | $2.62 B |
| 10/23/2024 | Q3 2024 | N/A | $2.01 | N/A | $2.43 B | $2.49 B |
| 07/24/2024 | Q2 2024 | N/A | $2.05 | N/A | $2.39 B | $2.40 B |
| 04/24/2024 | Q1 2024 | N/A | $1.74 | N/A | $2.29 B | $2.37 B |
| 02/22/2024 | Q4 2023 | N/A | $1.71 | N/A | $2.25 B | $2.29 B |
| 10/25/2023 | Q3 2023 | N/A | $1.99 | N/A | $2.27 B | $2.30 B |
| 07/27/2023 | Q2 2023 | N/A | $2.09 | N/A | $2.26 B | $2.34 B |
| 04/28/2023 | Q1 2023 | N/A | $1.79 | N/A | $2.20 B | $2.33 B |
| 02/21/2023 | Q4 2022 | N/A | $0.89 | N/A | $2.26 B | $2.33 B |
| 10/21/2022 | Q3 2022 | N/A | $2.19 | N/A | $2.35 B | $2.49 B |
| 07/22/2022 | Q2 2022 | N/A | $1.99 | N/A | $2.34 B | $2.45 B |
| 04/22/2022 | Q1 2022 | N/A | $2.97 | N/A | $2.64 B | $2.61 B |
| 02/28/2022 | Q4 2021 | N/A | $3.19 | N/A | $2.68 B | $2.74 B |
| 10/22/2021 | Q3 2021 | N/A | $4.11 | N/A | $2.45 B | $2.77 B |
| 07/23/2021 | Q2 2021 | N/A | $5.05 | N/A | $2.39 B | $2.55 B |
| 04/23/2021 | Q1 2021 | N/A | $3.52 | N/A | $2.64 B | $2.72 B |
| 02/22/2021 | Q4 2020 | N/A | $4.28 | N/A | $2.93 B | $3.00 B |
| 10/23/2020 | Q3 2020 | N/A | $4.20 | N/A | $2.72 B | $2.79 B |
| 07/24/2020 | Q2 2020 | N/A | $1.38 | N/A | $1.69 B | $1.83 B |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Quest Diagnostics Incorporated Earnings: FAQ's
Quest Diagnostics Incorporated has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, July 22nd, 2025 based offlast year's report dates.
In the previous quarter, Quest Diagnostics Incorporated (:DGX) reported $2.21 earnings per share (EPS) to beat the analysts' consensus estimate of $2.15 by $0.06.
The conference call for Quest Diagnostics Incorporated's latest earnings report can be listened to online.
The conference call transcript for Quest Diagnostics Incorporated's latest earnings report can be read online.
Quest Diagnostics Incorporated (:DGX) has a recorded annual revenue of $9.87 B.
Quest Diagnostics Incorporated (:DGX) has a recorded net income of $871.00 M.Quest Diagnostics Incorporated has generated $7.8 earnings per share over the last four quarters.
Quest Diagnostics Incorporated (:DGX) has a price-to-earnings ratio of 20.81 and price/earnings-to-growth ratio is 7.04.